GALLANT 4 Tesaglitazar vs. Glibenclamide

This study has been terminated.

( The development program has been terminated )

Study NCT00255541 Information provided by AstraZeneca

First Received: November 17, 2005 Last Updated: March 14, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2006
Estimated Primary Completion Date:	No date given